Illumina, Inc. to Buy NextBio for Undisclosed Amount; Backs 2013 Goals
Published: Oct 28, 2013
Illumina, Inc. (ILMN: Quote) has agreed to acquire Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio's powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. With the addition of NextBio's platform following the completion of the transaction, Illumina would be able to offer customers enterprise level bioinformatics solutions that accelerate the discovery of new associations between the human genome and disease, and ultimately, enable the application of those discoveries within healthcare.
Help employers find you! Check out all the jobs and post your resume.